Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.93B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.16B |
| 3 |
Albemarle
ALB
|
+$741M |
| 4 |
FRC
First Republic Bank
FRC
|
+$599M |
| 5 |
VICI Properties
VICI
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.16B |
| 2 |
Netflix
NFLX
|
+$1.04B |
| 3 |
Meta Platforms (Facebook)
META
|
+$872M |
| 4 |
EOG Resources
EOG
|
+$800M |
| 5 |
Intercontinental Exchange
ICE
|
+$700M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.46% |
| 2 | Healthcare | 16.89% |
| 3 | Financials | 14.17% |
| 4 | Communication Services | 10.18% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETRN
201
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $314M | 0.09% |
49,357,161
+117,654
| +0.2% | +$908K |
|
202
Trinity Industries
TRN
$2.33B
| $309M | 0.08% |
12,767,923
-28,907
| -0.2% | -$780K |
|
203
Nice
NICE
$5.82B
| $305M | 0.08% |
1,582,525
-45,459
| -3% | -$9.2M |
|
|
AXON
204
Axon Enterprise
AXON
$49B
| $304M | 0.08% |
3,259,618
+598,984
| +23% | +$63.3M |
|
205
Caterpillar
CAT
$396B
| $301M | 0.08% |
1,685,560
+289
| +0% | +$60.9K |
|
206
NVIDIA
NVDA
$5.45T
| $298M | 0.08% |
19,625,510
-10,438,700
| -35% | -$197M |
|
207
Kulicke & Soffa
KLIC
$5.05B
| $297M | 0.08% |
6,941,729
-218,719
| -3% | -$10.8M |
|
208
Iridium Communications
IRDM
$5.31B
| $296M | 0.08% |
7,870,167
+147,413
| +2% | +$5.5M |
|
209
The Mosaic Company
MOS
$6.82B
| $293M | 0.08% |
6,196,430
-9,025
| -0.1% | -$553K |
|
210
Waste Management
WM
$90B
| $292M | 0.08% |
1,909,738
+4,031
| +0.2% | +$631K |
|
211
CRISPR Therapeutics
CRSP
$5.21B
| $283M | 0.08% |
4,663,954
+1,061,802
| +29% | +$62.4M |
|
212
Gilead Sciences
GILD
$170B
| $283M | 0.08% |
4,572,801
-1,285,963
| -22% | -$79.6M |
|
213
Mattel
MAT
$4.2B
| $277M | 0.08% |
12,390,226
+741,309
| +6% | +$17.5M |
|
214
Helen of Troy
HELE
$699M
| $276M | 0.08% |
1,699,000
+283,404
| +20% | +$53.4M |
|
215
International Flavors & Fragrances
IFF
$21.5B
| $275M | 0.07% |
2,307,554
-847,800
| -27% | -$106M |
|
216
General Dynamics
GD
$106B
| $275M | 0.07% |
1,241,084
-277
| -0% | -$63.7K |
|
217
L3Harris
LHX
$53.7B
| $274M | 0.07% |
1,133,672
-1,855,097
| -62% | -$448M |
|
|
NVEI
218
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $270M | 0.07% |
7,479,933
+210,347
| +3% | +$11M |
|
219
ATI
ATI
$31.2B
| $267M | 0.07% |
11,777,609
-400,401
| -3% | -$10.6M |
|
220
Molson Coors Class B
TAP
$7.84B
| $265M | 0.07% |
4,859,117
+138,033
| +3% | +$7.41M |
|
221
Cable One
CABO
$198M
| $264M | 0.07% |
205,314
+1,029
| +0.5% | +$1.31M |
|
222
Old Dominion Freight Line
ODFL
$45.1B
| $258M | 0.07% |
2,011,956
| – | – |
|
|
DAY
223
DELISTED
Dayforce
DAY
| $253M | 0.07% |
5,373,944
+16,336
| +0.3% | +$907K |
|
224
RELX
RELX
$59.2B
| $248M | 0.07% |
9,199,143
-606,922
| -6% | -$17.5M |
|
225
Celanese
CE
$4.82B
| $247M | 0.07% |
2,100,846
-1,072,038
| -34% | -$154M |
|
Similar funds
Capital International Investors's Q2 2022 Portfolio in Review
As of Q2 2022, Capital International Investors held 470 positions worth $368B, down 16% from $439B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital International Investors's Q2 2022 filing shows 16 new, 197 increased, 171 reduced and 33 closed positions. Its largest new stake was Albemarle: 3,322,014 shares worth $694M. The largest sale was Eli Lilly, an estimated $1.16B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Capital International Investors's largest Q2 2022 buy was Albemarle: 3,322,014 shares worth $694M.
- Capital International Investors added most to AbbVie in Q2 2022, an estimated $1.93B increase.
- Capital International Investors's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $1.16B.
- Capital International Investors fully exited Marriott International in Q2 2022, selling an estimated $359M.
- Capital International Investors's ten largest holdings make up 27% of its $368B portfolio in Q2 2022.
- Capital International Investors opened 16 new positions and closed 33 in Q2 2022.
- Capital International Investors's portfolio value fell 16% quarter-over-quarter to $368B.
Based on Capital International Investors's 13F filing for Q2 2022, filed 15 Aug 2022.